Note: These statements are for information purposes and should not replace the clinical judgment of a physician, who must ultimately determine the appropriate treatment for each patient.

Background: Maternal mortality rates in Brazil remain above the goals established by the United Nations Sustainable Development Goals. Heart disease is estimated to affect 4% of all pregnancies and remains by itself the main indirect obstetric cause of maternal death. In the last decades, a significant improvement in the prognosis of heart diseases has made pregnancy possible in women with heart disease and provided better maternal and fetal outcomes.Objectives: To establish a multicenter Brazilian Registry of pregnant women with heart disease; to study the causes of immediate and late maternal mortality; and to assess the prevalence of heart disease in the country's macro-regions.Methods: This is an observational study, with retrospective and prospective stages, of the clinical and obstetric progression of pregnant women with heart disease. These women consecutively received care during pregnancy and will be followed up for up to a year after delivery at public and private hospitals with infrastructure for the execution of this project, a principal investigator, and approval by Ethics and Research Committees.Results: Our results will be presented after data collection and statistical analysis, aiming to demonstrate immediate and late maternal mortality rates, as well as the prevalence of heart disease in the country and its cardiovascular and obstetric complications during pregnancy.Conclusions: REBECGA will be the Brazilian Registry of heart disease and pregnancy and it will contribute to planning preventive measures, raising financial resources for the improvement of high-risk prenatal care, and reducing immediate and late maternal mortality due to heart disease.

Oliveira et al. Posicionamento sobre a Saúde Cardiovascular nas Mulheres -2022 Posicionamento sobre a Saúde Cardiovascular nas Mulheres -2022 O relatório abaixo lista as declarações de interesse conforme relatadas à SBC pelos especialistas durante o período de desenvolvimento deste posicionamento, 2022 Especialista Tipo de relacionamento com a indústria Alexandra Oliveira de Mesquita Nada a ser declarado Alexandre Jorge Gomes de Lucena Nada a ser declarado Andréa Araujo Brandão Declaração financeira A -Pagamento de qualquer espécie e desde que economicamente apreciáveis, feitos a (i) você, (ii) ao seu cônjuge/ companheiro ou a qualquer outro membro que resida com você, (iii) a qualquer pessoa jurídica em que qualquer destes seja controlador, sócio, acionista ou participante, de forma direta ou indireta, recebimento por palestras, aulas, atuação como proctor de treinamentos, remunerações, honorários pagos por participações em conselhos consultivos, de investigadores, ou outros comitês, etc. Provenientes da indústria farmacêutica, de órteses, próteses, equipamentos e implantes, brasileiras ou estrangeiras: -Servier: Acertil, Acertalix, Acertanlo, Triplixan. Outros relacionamentos Financiamento de atividades de educação médica continuada, incluindo viagens, hospedagens e inscrições para congressos e cursos, provenientes da indústria farmacêutica, de órteses, próteses, equipamentos e implantes, brasileiras ou estrangeiras: -Servier: Acertil, Acertalix, Acertanlo, Triplixan.

Nota: estes posicionamentos se prestam a informar e não a substituir o julgamento clínico do médico que, em última análise, deve determinar o tratamento apropriado para seus pacientes.

SUMMARY Cardiovascular diseases are the main cause of mortality in men and women worldwide, surpassing mortality from all associated neoplasms. In women, its prevalence and mortality increase at menopause, but complications of reproductive age, such as preeclampsia and eclampsia, lead to increased cardiovascular risk throughout their lives. Coronary ischemic disease is is the leading cause of death in Brazil and worldwide, with atherosclerotic disease being the principal pathophysiological mechanism. However, in women, other mechanisms are associated with myocardial ischemia, such as microcirculation disease and/or vasospasm, due to the anatomical and hormonal characteristics of women in different stages of their lives. Knowledge of the most prevalent cardiovascular diseases in women, as well as the specific risk factors, the traditional ones with the greatest impact, and the under-recognized ones, is of fundamental importance in their risk stratification, diagnosis, and management, fundamentally aiming at reducing mortality.